Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Leukemia
Interventions
DRUG

Dasatinib

Dasatinib was supplied as 20- and 50-mg tablets.

DRUG

Imatinib

Imatinib was supplied as 100- and 400-mg tablets.

Trial Locations (72)

34

Local Institution, Lima

1021

Local Institution, Buenos Aires

1097

Local Institution, Budapest

1280

Local Institution, Buenos Aires

1425

Local Institution, Capital Federal

2193

Local Institution, Parktown

4031

Local Institution, Basel

5000

Local Institution, Adelaide

5530

Local Institution, Mont-godinne

7006

Local Institution, Trondheim

10043

Local Institution, Orbassano (to)

10400

Local Institution, Bangkok

13083

Local Institution, Campinas

15224

Western Pennsylvania Hospital, Pittsburgh

20081

Local Institution, Lublin

20231

Local Institution, Rio de Janeiro

20246

Local Institution, Hamburg

31501

Local Institution, Krakow

33604

Local Institution, Pessac

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

40032

Local Institution, Katowice

40138

Local Institution, Bologna

41345

Local Institution, Gothenburg

44035

Local Institution, Nantes

46219

Central Indiana Cancer Centers, Indianapolis

48109

University Of Michigan Medical Center, Ann Arbor

48201

Wayne State University, Detroit

52621

Local Institution, Ramat Gan

59000

Local Institution, Lille

60637

University Of Chicago, Chicago

66205

University Of Kansas Medical Center, Westwood

67091

Local Institution, Strasbourg

68167

Local Institution, Mannheim

69437

Local Institution, Lyon

75390

Ut Southwestern Medical Center At Dallas, Dallas

75475

Local Institution, Paris

77030

The University Of Texas Md Anderson Cancer Center, Houston

80060

Local Institution, Curitiba

80131

Local Institution, Napoli

86021

Local Institution, Poitiers

90095

Ucla Department Of Medicine, Los Angeles

92354

Loma Linda University Cancer Center, Loma Linda

92801

Pacific Cancer Medical Center Inc, Anaheim

94305

Stanford University School Of Medicine, Stanford

94589

Kaiser Permanente Medical Center, Vallejo

97239

Oregon Health & Sci Univ, Portland

125167

Local Institution, Moscow

179089

Local Institution, Saint Petersburg

02215

Dana Faber Cancer Institute, Boston

07601

John Theurer Cancer Center, Hackensack

05403

Local Institution, São Paulo

05652

Local Institution, São Paulo

M4X 1K9

Local Institution, Toronto

H3A 1A1

Local Institution, Montreal

00029

Local Institution, Helsinki

04103

Local Institution, Leipzig

Unknown

Local Institution, Dublin

00144

Local Institution, Roma

LIMA II

Local Institution, Lima

93-510

Local Institution, Lodz

02097

Local Institution, Warsaw

0181

Local Institution, Groenkloof

519-809

Local Institution, Jeollanam-do

137-040

Local Institution, Seoul

08036

Local Institution, Barcelona

221 85

Local Institution, Lund

SE-17176

Local Institution, Stockholm

901 85

Local Institution, Umeå

751 85

Local Institution, Uppsala

W12 OHS

Local Institution, London

G12 OXB

Local Institution, Glasgow

NE2 4HH

Local Institution, Newcastle

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY